Pyruvate’s blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke
Authors:
- 21 September 2011
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 34 (9) , 1432-1441
Abstract
In previous studies, we have shown that by increasing the brain‐to‐blood glutamate efflux upon scavenging blood glutamate with either oxaloacetate or pyruvate, one achieves highly significant neuroprotection particularly in the context of traumatic brain injury. The current study examines, for the first time, how the blood glutamate scavenging properties of glutamate–pyruvate transaminase (GPT), alone or in combination with pyruvate, may contribute to the spectrum of its neuroprotective mechanisms and improve the outcome of rats exposed to brain ischemia, as they do after head trauma. Rats that were exposed to permanent middle cerebral artery occlusion (MCAO) and treated with intravenous 250 mg/kg pyruvate had a smaller volume of infarction and reduced brain edema, resulting in an improved neurological outcome and reduced mortality compared to control rats treated with saline. Intravenous pyruvate at the low dose of 31.3 mg/kg did not demonstrate any neuroprotection. However, when combined with 0.6 mg/kg of GPT there was a similar neuroprotection observed as seen with pyruvate at 250 mg/kg. Animals treated with 1.69 g/kg glutamate had a worse neurological outcome and a larger extent of brain edema. The decrease in mortality, infarcted brain volume and edema, as well as the improved neurological outcome following MCAO, was correlated with a decrease in blood glutamate levels. We therefore suggest that the blood glutamate scavenging activity of GPT and pyruvate contributes to the spectrum of their neuroprotective mechanisms and may serve as a new neuroprotective strategy for the treatment of ischemic stroke.Keywords
This publication has 40 references indexed in Scilit:
- Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levelsClinical Science, 2011
- High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic strokeJournal of Cerebral Blood Flow & Metabolism, 2011
- Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: An experimental studyJournal of Cerebral Blood Flow & Metabolism, 2011
- Pyruvate protects against experimental stroke via an anti-inflammatory mechanismNeurobiology of Disease, 2009
- Development of cerebral infarction, apoptotic cell death and expression of X-chromosome-linked inhibitor of apoptosis protein following focal cerebral ischemia in ratsLife Sciences, 2006
- Duration of Glutamate Release After Acute Ischemic StrokeStroke, 1997
- Neuroexcitatory Amino Acids and Their Relation to Infarct Size and Neurological Deficit in Ischemic StrokeStroke, 1996
- Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia.Stroke, 1991
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral MicrodialysisJournal of Neurochemistry, 1984